Theriva Biologics (TOVX) Accumulated Depreciation (2018 - 2026)
Theriva Biologics' Accumulated Depreciation came in at $1 million for Q2 2026, down 2.1% from $1.02 million a year earlier but up 2.1% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Accumulated Depreciation (2018 - 2026) Analysis & Trends
At the end of FY2025, Theriva Biologics' Accumulated Depreciation was $966,000, up 3.3% from FY2024.
- Accumulated Depreciation carries a five-year compound annual growth rate of -2.4% (FY2020 to FY2025).
- Going back by year, Accumulated Depreciation was $935,000 in FY2024 (-6.7%), $1 million in FY2023 (+15.8%), $865,000 in FY2022 (+4.1%) and $831,000 in FY2021 (-23.7%).
- The five-year range for quarterly Accumulated Depreciation is $813,000 (Q2 2022) to $1.15 million (Q1 2022).
- Year-over-year, Accumulated Depreciation increased in four of the last eight quarters, with growth averaging 1.0%.
- The fastest year-over-year change in Accumulated Depreciation over five years came in Q4 2023 (growth of 15.8%), and the weakest in Q4 2021 (a decline of 23.7%).
- Business Quant data shows TOVX's Accumulated Depreciation at $981,000 (Q1 2026), $966,000 (Q4 2025) and $988,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Theriva Biologics | 10.56 Mn | 10.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 981,000.00 |
| Dec 31, 2025 | 966,000.00 |
| Sep 30, 2025 | 988,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 973,000.00 |
| Dec 31, 2024 | 935,000.00 |
| Sep 30, 2024 | 927,000.00 |
| Jun 30, 2024 | 884,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 959,000.00 |
| Jun 30, 2023 | 930,000.00 |
| Mar 31, 2023 | 897,000.00 |
| Dec 31, 2022 | 865,000.00 |
| Sep 30, 2022 | 835,000.00 |
| Jun 30, 2022 | 813,000.00 |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 831,000.00 |
| Sep 30, 2021 | 817,000.00 |
API Access
Theriva Biologics Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();